MetLife Investment Management’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $110K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $57K | Hold |
|
|||||
|
2023
Q1 | $99K | Sell |
|
|||||
|
2022
Q4 | $288K | Hold |
|
|||||
|
2022
Q3 | $251K | Buy |
|
|||||
|
2022
Q2 | $215K | Sell |
|
|||||
|
2022
Q1 | $331K | Buy |
|
|||||
|
2021
Q4 | $222K | Hold |
|
|||||
|
2021
Q3 | $281K | Hold |
|
|||||
|
2021
Q2 | $260K | Hold |
|
|||||
|
2021
Q1 | $395K | Hold |
|
|||||
|
2020
Q4 | $276K | Hold |
|
|||||
|
2020
Q3 | $232K | Hold |
|
|||||
|
2020
Q2 | $311K | Hold |
|
|||||
|
2020
Q1 | $241K | Hold |
|
|||||
|
2019
Q4 | $293K | Hold |
|
|||||
|
2019
Q3 | $333K | Buy |
|
|||||
|
2019
Q2 | $337K | Hold |
|
|||||
|
2019
Q1 | $308K | Hold |
|
|||||
|
2018
Q4 | $204K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $220K | Hold |
|
|||||
|
2018
Q1 | $142K | Hold |
|
|||||
|
2017
Q4 | $140K | Buy |
|